Principal Exchange-Traded Funds Principal Focused Blue Chip ETF (BATS: BCHP)

Latest news for Principal Exchange-Traded Funds Principal Focused Blue Chip ETF (BATS:BCHP)

Technology

Financial Services

Consumer Cyclical

Industrials

Real Estate

Healthcare

Communication Services

Under normal circumstances, the Fund invests at least 80 percent of its net assets, plus any borrowings for investment purposes, in equity securities of companies with large market capitalizations at the time of purchase that, in the opinion of Principal Global Investors, LLC, the Fund's investment advisor, display characteristics of a blue-chip company. The Fund is an actively managed non-transparent ETF that operates pursuant to an exemptive order from the Securities and Exchange Commission (Non-Transparent Order) and does not publicly disclose its complete portfolio holdings each business day. Instead, the Fund publishes each business day on its website a Tracking Basket, which is designed to closely track the daily performance of the Fund but is not the Funds actual portfolio. The Tracking Basket is comprised of select recently disclosed portfolio holdings; liquid ETFs that convey information about the types of instruments that are not otherwise fully represented by the Strategy Components in which the Fund invests; and cash and cash equivalents.

Microsoft Corp

Alphabet Holding Company Inc.

Amazon.Com Inc

Mastercard Inc

Transdigm Group Inc.

Brookfield Corp

Danaher Corp.

Progressive Corp.

Visa Inc

Intuit, Inc.

Principal Focused Blue Chip ETF

Mahmutlar, - ,Turkey,-,June,01,,2019:,Mastercard,Plastic,Electronic

Analyst Color

Equities

Large Cap

News

Downgrades

Price Target

Analyst Ratings

Trading Ideas

BCHP

iShares Trust Dow Jones US Financial Services Index Fund

Analyst downgraded Mastercard to Neutral with $521 PT. Revenue upside limited due to international exposure. No catalysts this year. 

Mastercard Is Fairly Valued And Lacks An Identifiable Catalyst; Analyst Downgrades Stock

Principal Exchange-Traded Funds Principal Focused Blue Chip ETF

BRAINCHIP HLDGS LTD S/ADR by Brainchip Holdings Ltd.

BrainChip Holdings Ltd

OS Therapies reiterates clinical and regulatory path in recurrent, fully respected osteosarcoma with lung metastases, an indication with no currently approved treatments.
 &nbsp;

OSTX

OS Therapies Says Phase 2b Clinical Trial Of OST-HER2 Achieves Primary Endpoint With Statistical Significance In Prevention Of Recurrent, Fully Resected, Lung Metastatic Osteosarcoma

Interview

BlackRock CEO Larry Fink Says Don't Believe You'll See BlackRock In The Market Buying Whole Companies

Evercore ISI Group analyst James West downgrades Helmerich &amp; Payne (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HP#NYSE">HP</a>) from Outperform to In-Line and lowers the price target from $48 to $39.

Evercore ISI Group Downgrades Helmerich & Payne to In-Line, Lowers Price Target to $39

WIIM

Bank of New York Mellon shares are trading higher following better-than-expected Q4 financial results.

SPRC

SciSparc Says It Is Granted 180-Day Extension Until July 14, 2025, By Nasdaq To Regain Compliance With Minimum Bid Requirement

GS: 3% &#x7C; <a href="https://www.benzinga.com//node/42999133">Goldman Sachs Q4 Investment Banking Fees Rose 24% YoY, Global Banking &amp; Markets Revenue Rose 33%, Provision For Credit Losses Fell 39%</a>
&nbsp;
VCEL: -12% &#x7C; <a href="https://www.benzinga.com//node/42997435">Vericel shares are trading lower after the company issued preliminary FY24 and Q4 net revenue below estimates.</a>
&nbsp;
COMP: 11% &#x7C; <a href="https://www.benzinga.com//node/42998131">Compass shares are trading higher after the company raised its Q4 and FY24 guidance.</a>

Movers

COMP

VCEL

Market-Moving News for January 15th

AVXL

Anavex Life Sciences Reveals Peer-reviewed Publication Of Oral Blarcamesine Phase IIb/III Data In Journal Of Prevention Of Alzheimer's Disease

Seaport Global analyst Kenneth Zener upgrades KB Home (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KBH#NYSE">KBH</a>) from Sell to Neutral.

Upgrades

Seaport Global Upgrades KB Home to Neutral

Prairie expects Average Daily Production: 7,000 – 8,000 barrels of oil equivalent per day (BOEPD), representing a ~300% increase year-over-year.
Prairie plans to actively pursue additional strategic acquisition opportunities, the completion of which will result in an update to guidance to reflect the enhanced scale and value of the Company.

Guidance

PROP

Prairie Operating Expects 2025 Net Income  Of $69M - $102M, Adjusted EBITDA Of $100M - $140M,

Earnings

Goldman Sachs Total Loans Increased 7% During The Year

QBTS

D-wave Quantum Inks Pact With Carahsoft Partner To Expand Distribution Of Quantum Computing Solutions To The Public Sector

Rosenblatt analyst Blair Abernethy maintains Silvaco Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SVCO#NASDAQ">SVCO</a>) with a Buy and maintains $18 price target.

SVCO

Rosenblatt Maintains Buy on Silvaco Group, Maintains $18 Price Target

ZLAB

Zai Lab Highlights Topline Results For TIVDAK In China Subpopulation Of Global Phase 3 innovaTV 301 Trial In Patients With Recurrent or Metastatic Cervical Cancer

Contracts

STRM

Streamline Health Signs New Contract For Use Of eValuator With Deaconess Health System

Goldman Sachs Q4 Investment Banking Fees Rose 24% YoY, Global Banking & Markets Revenue Rose 33%, Provision For Credit Losses Fell 39%

D. Boral Capital analyst Jesse Sobelson maintains New Horizon Aircraft (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HOVR#NASDAQ">HOVR</a>) with a Buy and maintains $2 price target.

HOVR

D. Boral Capital Maintains Buy on New Horizon Aircraft, Maintains $2 Price Target

Needham analyst Chris Pierce reiterates TrueCar (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TRUE#NASDAQ">TRUE</a>) with a Buy and maintains $5 price target.

Reiteration

TRUE

Needham Reiterates Buy on TrueCar, Maintains $5 Price Target

D. Boral Capital analyst Jason Kolbert maintains Context Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CNTX#NASDAQ">CNTX</a>) with a Buy and maintains $9 price target.

CNTX

D. Boral Capital Maintains Buy on Context Therapeutics, Maintains $9 Price Target

Goldman Sachs shares are trading higher following better-than-expected Q4 financial results.

XRP (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/xrp/usd">XRP</a>) has sustained <a href="https://www.benzinga.com/money/ripple-xrp-price-prediction">its bullish momentum</a> for the second consecutive day, driven by speculation around an XRP ETF and increasing whale transactions. 
<figure class="wp-block-table"> 
<table>
<tbody>
<tr>
<td>Cryptocurrency</td>
<td>Price&nbsp;&nbsp;&nbsp;</td>
<td>Market Cap</td>
<td>24-Hour Trend</td>
<td>7-Day Trend</td>
</tr>
<tr>
<td>XRP (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/xrp/usd">XRP</a>)</td>
<td>&nbsp;$2.76</td>
<td>$158.5 billion</td>
<td>+7.5%&nbsp;</td>
<td>+19%&nbsp;</td>
</tr>
<tr>
<td>Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>)</td>
<td>&nbsp;$96,664.83</td>
<td>$1.9 trillion</td>
<td>+0.2%&nbsp;</td>
<td>+1.6%&nbsp;</td>
</tr>
<tr>
<td>Ethereum (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/eth/usd">ETH</a>)</td>
<td>&nbsp;$3,197.98</td>
<td>$385.4 billion</td>
<td>-0.5%&nbsp;</td>
<td>-4.5%&nbsp;</td>
</tr>
</tbody>
</table>
</figure>
Trader Notes: Crypto trader Cold Blooded Shiller described XRP as an "alive monster," predicting its ascent to $4.2 if the rally maintains momentum.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">The <a href="https://twitter.com/search?q=%24XRP&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$XRP</a> monster is alive. Pushing against the highs, won&#39;t be long before this breaks and continues it&#39;s ascent upward. $4.20. <a href="https://t.co/srLuW0zF2T">https://t.co/srLuW0zF2T</a> <a href="https://t.co/oOk0X8Jcko">pic.twitter.com/oOk0X8Jcko</a>
&mdash; Cold Blooded Shiller (@ColdBloodShill) <a href="https://twitter.com/ColdBloodShill/status/1879458140808524140?ref_src=twsrc%5Etfw">January 15, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Crypto trader Satoshi Flipper suggested XRP is on the verge of price discovery, indicating the potential for new highs.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">PRICE DISCOVERY FOR <a href="https://twitter.com/search?q=%24XRP&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$XRP</a> LOADING <a href="https://t.co/BQXCcZawgW">pic.twitter.com/BQXCcZawgW</a>
&mdash; Satoshi Flipper (@SatoshiFlipper) <a href="https://twitter.com/SatoshiFlipper/status/1879479514813927862?ref_src=twsrc%5Etfw">January 15, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Statistics: Santiment data highlighted by crypto chart analyst Ali Martinez <a href="https://x.com/ali_charts/status/1879457747537670249">shows</a> transactions over $1 million surged to 341 in the last 24 hours.
Coinglass reported XRP futures open interest reached $6 billion (as of Jan. 15), marking an 18% daily increase, the highest since December.
Derivatives trading volume rose 25%, while XRP spot inflows hit $99.3 million, a record high since Dec. 1, 2024.
Community News: David Gokhshtein, founder of Gokhshtein Media, <a href="https://x.com/davidgokhshtein/status/1879352526119850390">acknowledged</a> the rally, stating XRP holders "deserve" this momentum.
Omni Foundation co-founder Austin King <a href="https://x.com/0xASK/status/1879364677316321362">shared</a> insights into Ripple&#8217;s broader vision, beyond the anticipated XRP ETF launch in 2025:
<ul>
<li>Ripple plans to expand its fast, low-cost payment solutions to attract customers from traditional finance.</li>
<li>The company has processed over $50 billion in payments and aims to position the XRP Ledger as the hub for tokenizing global financial assets.</li>
</ul>
Jan. 15 marks the SEC's deadline to file an opening brief in its appeal against Judge Torres' ruling. 
Speculation remains over whether the SEC will contest XRP's classification as a security in programmatic sales.
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/01/42985959/xrp-up-16-in-7-days-could-it-temporarily-flip-ethereum-or-even-bitcoin">XRP Up 16% In 7 Days: Could It Temporarily Flip Ethereum Or Even Bitcoin?</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$BTC

$ETH

$XRP

XRP Price Surges Another 7.5%: What Is Going On?

Seaport analyst Jeff Cantwell downgraded Mastercard Incorporated (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MA#NYSE">MA</a>) to Neutral from Buy rating, <a target="_blank" href="https://www.benzinga.com/quote/MA/analyst-ratings" rel="noreferrer noopener">with a price target of $521</a>.



The analyst writes that he continues to like Mastercard&#8217;s story but views the shares as fairly valued at this point.



Revenue upside in 2025 appears more limited due to its higher international exposure compared to Visa, and Mastercard lacks an identifiable catalyst, adds the analyst.



Last year, the analyst favored Mastercard over Visa. However, this year, the analyst prefers Visa relative to Mastercard, highlighting that Visa&#8217;s volumes and revenue are more U.S.-centric, where expectations are rising, while Mastercard is more exposed to international markets, which face greater risks to PCE growth.



Related: <a target="_blank" href="https://www.benzinga.com//node/42986061" rel="noreferrer noopener">This Analyst Prefers Visa Over Mastercard In 2025 &#8211; Here&#8217;s Why</a>



Additionally, with Mastercard&#8217;s Investor Day already passed, the analyst doesn&#8217;t see any identifiable catalysts for the stock this year.



Cantwell says that with the upcoming administration change in the U.S., 2025 is expected to be fluid, requiring investors to stay vigilant.



Potential policy adjustments could impact consumer and business spending, and factors like FX, inflation, and the Fed&#8217;s rate cuts further complicate the outlook, adds the analyst.



The analyst foresees a higher potential for earnings surprises in Fintech this year compared to previous years.



Investors can gain exposure to the stock via Principal Exchange-Traded Funds Principal Focused Blue Chip ETF (BATS:<a class="ticker" href="https://www.benzinga.com/stock/BCHP#BATS">BCHP</a>) and iShares U.S. Financial Services ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IYG#NYSE">IYG</a>).



Price Action: MA shares are up 0.78% at $508.83 at the last check Tuesday.



Read Next:



<ul>
<li><a href="https://www.benzinga.com/25/01/42971921/mastercard-vs-visa-bearish-trends-bullish-hopes" target="_blank" rel="noreferrer noopener">Mastercard Vs. Visa: Technical Challenges Ahead Of Earnings Showdown</a></li>
</ul>



Photo via Shutterstock.

Comments

Principal Exchange-Traded Funds Principal Focused Blue Chip ETF

News

Latest news for Principal Exchange-Traded Funds Principal Focused Blue Chip ETF (BATS:BCHP)

Tuesday, January 14, 2025

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga